About Neucyte
Neucyte is a company based in Sunnyvale (United States) founded in 2015 by Tao Huang.. Neucyte has raised $6.7 million across 2 funding rounds from investors including HHS, Co-win Ventures and Leaguer. The company has 10 employees as of December 31, 2023. Neucyte offers products and services including SynFire Technology and MaxTwo Microelectrode Arrays. Neucyte operates in a competitive market with competitors including Newcells Biotech, InSphero, Pandorum, Vivodyne and NextVivo, among others.
- Headquarter Sunnyvale, United States
- Employees 10 as on 31 Dec, 2023
- Founders Tao Huang
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Neucyte, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$6.7 M (USD)
in 2 rounds
-
Latest Funding Round
$500 K (USD), Grant
Sep 15, 2024
-
Investors
HHS
& 2 more
-
Employee Count
10
as on Dec 31, 2023
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Neucyte
Neucyte offers a comprehensive portfolio of products and services, including SynFire Technology and MaxTwo Microelectrode Arrays. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Generates iPSC-derived neurons for CNS target validation.
Enables functional characterization of neural cells in assays.
Unlock access to complete
Unlock access to complete
Funding Insights of Neucyte
Neucyte has successfully raised a total of $6.7M across 2 strategic funding rounds. The most recent funding activity was a Grant round of $500 thousand completed in September 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Grant — $500,000
-
First Round
First Round
(08 May 2018)
- Investors Count 3
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep, 2024 | Amount | Grant - Neucyte | Valuation |
investors |
|
| May, 2018 | Amount | Series A - Neucyte | Valuation | Co-win Ventures , Leaguer Group |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Neucyte
Neucyte has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include HHS, Co-win Ventures and Leaguer. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
VC fund investing in startups
|
Founded Year | Domain | Location | |
|
Leaguer is engaged in technology transfer and innovation services.
|
Founded Year | Domain | Location | |
|
Public health and human services are overseen by HHS.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Neucyte
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Neucyte
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Neucyte Comparisons
Competitors of Neucyte
Neucyte operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Newcells Biotech, InSphero, Pandorum, Vivodyne and NextVivo, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Induced pluripotent stem cell-derived organoid models are developed for research.
|
|
| domain | founded_year | HQ Location |
Cell-based assays and 3D microtissues for drug screening are developed.
|
|
| domain | founded_year | HQ Location |
Regenerative medicine and 3D tissues are developed for therapeutic uses.
|
|
| domain | founded_year | HQ Location |
Developer of AI-based platform for lab-grown human tissues
|
|
| domain | founded_year | HQ Location |
Immune-competent human-derived models are developed for drug discovery applications.
|
|
| domain | founded_year | HQ Location |
Provider of computational tools for bacterial metabolomic and genomic data analysis
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Neucyte
Frequently Asked Questions about Neucyte
When was Neucyte founded?
Neucyte was founded in 2015 and raised its 1st funding round 3 years after it was founded.
Where is Neucyte located?
Neucyte is headquartered in Sunnyvale, United States. It is registered at Sunnyvale, California, United States.
Is Neucyte a funded company?
Neucyte is a funded company, having raised a total of $6.7M across 2 funding rounds to date. The company's 1st funding round was a Series A of $6.7M, raised on May 08, 2018.
How many employees does Neucyte have?
As of Dec 31, 2023, the latest employee count at Neucyte is 10.
What does Neucyte do?
Neucyte was founded in 2015 and is located in Sunnyvale, United States, within the biotechnology sector focused on neuroscience. Reprogramming technology is utilized to generate homogenous populations of various neuronal subtypes. Human neural in vitro systems are offered for evaluating higher-order electrophysiology, which aids in predicting drug efficacy and assessing potential CNS safety or toxicology risks. Human-specific neural phenotypes are examined through this platform, features absent in animal models.
Who are the top competitors of Neucyte?
Neucyte's top competitors include Newcells Biotech, InSphero and Vivodyne.
What products or services does Neucyte offer?
Neucyte offers SynFire Technology and MaxTwo Microelectrode Arrays.
Who are Neucyte's investors?
Neucyte has 3 investors. Key investors include HHS, Co-win Ventures, and Leaguer.